Contract Research Organization (CRO), also sometimes referred as also referred as clinical research organization are key constituent of the drug development process, offers range of services to pharmaceutical and biopharmaceutical companies. CRO's can provide services such as early phase development services (includes discovery studies, chemistry, manufacturing & control), Pharmacokinetics/Pharmacodynamics (PK/PD), toxicology testing, clinic research services (Phase I, Phase II, Phase III, Phase IV), laboratory services, analytical and bioanalytical testing, physical characterization, and consulting services. CRO also extend their services to governmental institutes, Universities, in addition to research institutions. CRO's help in the drug development various major diseases such as oncology, cardiovascular disease, diabetes, infectious diseases, CNS disorders, respiratory disorders and other disorders.
Major Key Players of the Contract Research Organization (CRO) Market are:Charles River Laboratories International (CRL), Medpace, PRA Health Sciences, Clinipace, ICON, CMIC, LabCorp (Covance), Parexel International Corporation, Laboratory Corporation of America Holdings, PPD, EPS International, IQVIA (Quintiles IMS), RxCelerate, Optimapharm, Syneos Health
 |
| Contract Research Organization (CRO) MarketAdd caption |
No comments:
Post a Comment